ENO2 and hepatocellular carcinoma: Overall, we identified 100 non-kinase DGIdb druggable proteins that were significantly overexpressed (FDR < 0.05) in both HCC cohorts, including POSTN, CYP3A5, ANXA3, ENO2, and VCAM1 (Figure 2C and Figure S3).